Haemovigilance is a set of surveillance procedures covering the whole transfusion chain (from the collection of blood and its components to the follow-up of recipients), intended to collect and assess information or unexpected or undesirable effects resulting from the therapeutic use of blood products, and to prevent their occurrence or recurrence.
National Safety and Quality Health Service Standard 7 on Blood and Blood Products requires health service organisations to ensure that adverse events are included in their incident management and investigation systems, and that they participate in haemovigilance activities conducted at state or national levels.
As required by Standard 7, Hospital and Health Services and licensed private health facilities will report incidents related to blood and blood products and implement local haemovigilance activities, which may include:
The Department of Health’s role in haemovigilance is to:
coordinate data provision from HHSs and licensed private health facilities to the National Blood Authority for national haemovigilance reporting.
It is recommended that hospitals: